|
⚲
|
| Keyboard |
| Ramelmeier Rolf Andrew
✚
|
|
|---|---|
| CIK # | 0001789340 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001789340] | |
| 4 | [0001789340] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Ramelmeier Rolf Andrew | |
| Sangamo Therapeutics Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Sangamo Therapeutics Inc SGMO
Common Stock
|
2023-05-25 | Tax withheld | 1,750 | $1.33 | 2,328 |
|
Sangamo Therapeutics Inc SGMO
Common Stock
|
2023-02-25 | Tax withheld | 15,618 | $2.66 | 41,544 |
|
Sangamo Therapeutics Inc SGMO
Common Stock
|
2023-02-24 | Grant | 45,000 | $0.00 | |
|
Sangamo Therapeutics Inc SGMO
Stock Option (Right to Buy) · derivative
|
2023-02-24 | Grant | 210,000 | $0.00 | |
|
Sangamo Therapeutics Inc SGMO
Common Stock
|
2022-02-25 | Grant | 54,000 | $0.00 | |
|
Sangamo Therapeutics Inc SGMO
Common Stock
|
2022-02-25 | Tax withheld | 12,388 | $5.90 | 73,089 |
|
Sangamo Therapeutics Inc SGMO
Stock Option (Right to Buy) · derivative
|
2022-02-25 | Grant | 145,800 | $0.00 | |
|
Sangamo Therapeutics Inc SGMO
Stock Option (Right to Buy) · derivative
|
2021-02-25 | Grant | 80,000 | $0.00 | |
|
Sangamo Therapeutics Inc SGMO
Common Stock
|
2021-02-25 | Tax withheld | 7,779 | $11.19 | 87,047 |
|
Sangamo Therapeutics Inc SGMO
Common Stock
|
2021-02-25 | Grant | 40,000 | $0.00 | |
|
Sangamo Therapeutics Inc SGMO
Common Stock
|
2020-12-31 | Sell | 2,464 | $16.74 | 41,247 |
|
Sangamo Therapeutics Inc SGMO
Common Stock
|
2020-12-24 | Sell | 3,331 | $18.13 | 60,391 |
|
Sangamo Therapeutics Inc SGMO
Common Stock
|
2020-02-25 | Tax withheld | 1,703 | $6.80 | 11,580 |
|
Sangamo Therapeutics Inc SGMO
Stock Option (Right-to-Buy) · derivative
|
2020-02-25 | Grant | 110,000 | $0.00 | |
|
Sangamo Therapeutics Inc SGMO
Common Stock
|
2020-02-25 | Grant | 55,000 | $0.00 |